nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—SLC22A7—Fluorouracil—urinary bladder cancer	0.229	0.513	CbGbCtD
Oxtriphylline—SLC22A7—Methotrexate—urinary bladder cancer	0.126	0.283	CbGbCtD
Oxtriphylline—CYP1A2—Fluorouracil—urinary bladder cancer	0.0495	0.111	CbGbCtD
Oxtriphylline—CYP1A2—Etoposide—urinary bladder cancer	0.0413	0.0928	CbGbCtD
Oxtriphylline—PDE3A—penis—urinary bladder cancer	0.0343	0.148	CbGeAlD
Oxtriphylline—Caffeine—ATM—urinary bladder cancer	0.0158	1	CrCbGaD
Oxtriphylline—PDE3B—prostate gland—urinary bladder cancer	0.0134	0.0579	CbGeAlD
Oxtriphylline—PDE4D—prostate gland—urinary bladder cancer	0.0112	0.0483	CbGeAlD
Oxtriphylline—ADORA2B—prostate gland—urinary bladder cancer	0.0111	0.048	CbGeAlD
Oxtriphylline—CYP1A2—urine—urinary bladder cancer	0.0101	0.0436	CbGeAlD
Oxtriphylline—PDE4A—prostate gland—urinary bladder cancer	0.00991	0.0428	CbGeAlD
Oxtriphylline—PDE3A—prostate gland—urinary bladder cancer	0.0082	0.0354	CbGeAlD
Oxtriphylline—HDAC2—Teniposide—Etoposide—urinary bladder cancer	0.00809	1	CbGdCrCtD
Oxtriphylline—HDAC2—prostate gland—urinary bladder cancer	0.00789	0.0341	CbGeAlD
Oxtriphylline—ADORA2B—smooth muscle tissue—urinary bladder cancer	0.00787	0.034	CbGeAlD
Oxtriphylline—ADORA2B—urethra—urinary bladder cancer	0.00745	0.0321	CbGeAlD
Oxtriphylline—SLC22A7—renal system—urinary bladder cancer	0.00625	0.027	CbGeAlD
Oxtriphylline—PDE4B—prostate gland—urinary bladder cancer	0.00591	0.0255	CbGeAlD
Oxtriphylline—PDE3A—smooth muscle tissue—urinary bladder cancer	0.0058	0.0251	CbGeAlD
Oxtriphylline—HDAC2—epithelium—urinary bladder cancer	0.0058	0.025	CbGeAlD
Oxtriphylline—HDAC2—smooth muscle tissue—urinary bladder cancer	0.00559	0.0241	CbGeAlD
Oxtriphylline—ADORA2B—vagina—urinary bladder cancer	0.00549	0.0237	CbGeAlD
Oxtriphylline—ADORA1—renal system—urinary bladder cancer	0.00545	0.0235	CbGeAlD
Oxtriphylline—HDAC2—renal system—urinary bladder cancer	0.00538	0.0232	CbGeAlD
Oxtriphylline—ADORA1—urethra—urinary bladder cancer	0.00535	0.0231	CbGeAlD
Oxtriphylline—ADORA2A—female reproductive system—urinary bladder cancer	0.00505	0.0218	CbGeAlD
Oxtriphylline—PDE3A—female reproductive system—urinary bladder cancer	0.00448	0.0193	CbGeAlD
Oxtriphylline—ADORA1—female reproductive system—urinary bladder cancer	0.00436	0.0188	CbGeAlD
Oxtriphylline—HDAC2—female reproductive system—urinary bladder cancer	0.00431	0.0186	CbGeAlD
Oxtriphylline—PDE3B—lymph node—urinary bladder cancer	0.00429	0.0185	CbGeAlD
Oxtriphylline—PDE4B—urethra—urinary bladder cancer	0.00396	0.0171	CbGeAlD
Oxtriphylline—ADORA1—vagina—urinary bladder cancer	0.00394	0.017	CbGeAlD
Oxtriphylline—HDAC2—vagina—urinary bladder cancer	0.0039	0.0168	CbGeAlD
Oxtriphylline—PDE4D—lymph node—urinary bladder cancer	0.00358	0.0154	CbGeAlD
Oxtriphylline—PDE4B—female reproductive system—urinary bladder cancer	0.00323	0.0139	CbGeAlD
Oxtriphylline—PDE4A—lymph node—urinary bladder cancer	0.00316	0.0137	CbGeAlD
Oxtriphylline—PDE4B—vagina—urinary bladder cancer	0.00292	0.0126	CbGeAlD
Oxtriphylline—PDE3A—lymph node—urinary bladder cancer	0.00262	0.0113	CbGeAlD
Oxtriphylline—ADORA1—lymph node—urinary bladder cancer	0.00255	0.011	CbGeAlD
Oxtriphylline—HDAC2—lymph node—urinary bladder cancer	0.00252	0.0109	CbGeAlD
Oxtriphylline—CYP1A2—renal system—urinary bladder cancer	0.00247	0.0107	CbGeAlD
Oxtriphylline—PDE4B—lymph node—urinary bladder cancer	0.00189	0.00814	CbGeAlD
Oxtriphylline—ADORA2B—Signaling Pathways—CREBBP—urinary bladder cancer	6.79e-05	0.000227	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—FGFR3—urinary bladder cancer	6.78e-05	0.000227	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—RHOA—urinary bladder cancer	6.73e-05	0.000225	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IGF1—urinary bladder cancer	6.7e-05	0.000224	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—FGFR3—urinary bladder cancer	6.7e-05	0.000224	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—EGFR—urinary bladder cancer	6.67e-05	0.000223	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.6e-05	0.000221	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—HRAS—urinary bladder cancer	6.59e-05	0.00022	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ESR1—urinary bladder cancer	6.59e-05	0.00022	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CREBBP—urinary bladder cancer	6.58e-05	0.00022	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	6.54e-05	0.000219	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ESR1—urinary bladder cancer	6.51e-05	0.000218	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IGF1—urinary bladder cancer	6.5e-05	0.000217	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CREBBP—urinary bladder cancer	6.48e-05	0.000217	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NCOR1—urinary bladder cancer	6.47e-05	0.000217	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—EGFR—urinary bladder cancer	6.47e-05	0.000216	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IGF1—urinary bladder cancer	6.4e-05	0.000214	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—EGFR—urinary bladder cancer	6.36e-05	0.000213	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—IL2—urinary bladder cancer	6.31e-05	0.000211	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—KRAS—urinary bladder cancer	6.3e-05	0.000211	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—ERBB2—urinary bladder cancer	6.23e-05	0.000208	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—RHOA—urinary bladder cancer	6.19e-05	0.000207	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	6.18e-05	0.000207	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CREBBP—urinary bladder cancer	6.16e-05	0.000206	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—RHOA—urinary bladder cancer	6.14e-05	0.000205	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TERT—urinary bladder cancer	6.14e-05	0.000205	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—KRAS—urinary bladder cancer	6.11e-05	0.000204	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IGF1—urinary bladder cancer	6.09e-05	0.000204	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—EGFR—urinary bladder cancer	6.06e-05	0.000203	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	6.02e-05	0.000201	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—KRAS—urinary bladder cancer	6.01e-05	0.000201	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CREBBP—urinary bladder cancer	6e-05	0.000201	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CXCL8—urinary bladder cancer	5.99e-05	0.0002	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—RHOA—urinary bladder cancer	5.96e-05	0.000199	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IGF1—urinary bladder cancer	5.92e-05	0.000198	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CXCL8—urinary bladder cancer	5.91e-05	0.000198	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—EGFR—urinary bladder cancer	5.89e-05	0.000197	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—HRAS—urinary bladder cancer	5.87e-05	0.000196	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—RHOA—urinary bladder cancer	5.86e-05	0.000196	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CREBBP—urinary bladder cancer	5.77e-05	0.000193	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—ERBB2—urinary bladder cancer	5.73e-05	0.000192	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL2—urinary bladder cancer	5.73e-05	0.000192	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—KRAS—urinary bladder cancer	5.72e-05	0.000191	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TERT—urinary bladder cancer	5.71e-05	0.000191	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CREBBP—urinary bladder cancer	5.7e-05	0.000191	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IGF1—urinary bladder cancer	5.7e-05	0.000191	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—ERBB2—urinary bladder cancer	5.69e-05	0.00019	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—EGFR—urinary bladder cancer	5.67e-05	0.00019	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL2—urinary bladder cancer	5.65e-05	0.000189	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IGF1—urinary bladder cancer	5.63e-05	0.000188	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FGFR3—urinary bladder cancer	5.63e-05	0.000188	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—urinary bladder cancer	5.61e-05	0.000187	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—EGFR—urinary bladder cancer	5.61e-05	0.000187	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—RHOA—urinary bladder cancer	5.58e-05	0.000187	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—KRAS—urinary bladder cancer	5.57e-05	0.000186	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—ERBB2—urinary bladder cancer	5.51e-05	0.000184	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCND1—urinary bladder cancer	5.5e-05	0.000184	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ESR1—urinary bladder cancer	5.47e-05	0.000183	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—RHOA—urinary bladder cancer	5.43e-05	0.000181	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—ERBB2—urinary bladder cancer	5.42e-05	0.000181	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CXCL8—urinary bladder cancer	5.39e-05	0.00018	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—KRAS—urinary bladder cancer	5.36e-05	0.000179	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—HRAS—urinary bladder cancer	5.36e-05	0.000179	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MMP9—urinary bladder cancer	5.34e-05	0.000179	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CDKN1A—urinary bladder cancer	5.33e-05	0.000178	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PTEN—urinary bladder cancer	5.31e-05	0.000178	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—KRAS—urinary bladder cancer	5.3e-05	0.000177	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FGFR3—urinary bladder cancer	5.24e-05	0.000175	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CXCL8—urinary bladder cancer	5.23e-05	0.000175	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—RHOA—urinary bladder cancer	5.22e-05	0.000175	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—HRAS—urinary bladder cancer	5.2e-05	0.000174	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ERBB2—urinary bladder cancer	5.16e-05	0.000173	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—RHOA—urinary bladder cancer	5.16e-05	0.000173	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL2—urinary bladder cancer	5.15e-05	0.000172	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CXCL8—urinary bladder cancer	5.14e-05	0.000172	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—HRAS—urinary bladder cancer	5.11e-05	0.000171	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ESR1—urinary bladder cancer	5.09e-05	0.00017	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—EP300—urinary bladder cancer	5.07e-05	0.000169	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCND1—urinary bladder cancer	5.02e-05	0.000168	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ERBB2—urinary bladder cancer	5.02e-05	0.000168	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL2—urinary bladder cancer	5e-05	0.000167	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—SRC—urinary bladder cancer	4.93e-05	0.000165	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL2—urinary bladder cancer	4.92e-05	0.000164	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CDKN1A—urinary bladder cancer	4.9e-05	0.000164	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CXCL8—urinary bladder cancer	4.9e-05	0.000164	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTEN—urinary bladder cancer	4.89e-05	0.000164	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MMP9—urinary bladder cancer	4.88e-05	0.000163	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCND1—urinary bladder cancer	4.87e-05	0.000163	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—HRAS—urinary bladder cancer	4.86e-05	0.000163	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	4.86e-05	0.000163	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PTEN—urinary bladder cancer	4.85e-05	0.000162	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ERBB2—urinary bladder cancer	4.83e-05	0.000162	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.83e-05	0.000161	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TYMP—urinary bladder cancer	4.81e-05	0.000161	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CREBBP—urinary bladder cancer	4.79e-05	0.00016	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCND1—urinary bladder cancer	4.79e-05	0.00016	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ERBB2—urinary bladder cancer	4.78e-05	0.00016	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CXCL8—urinary bladder cancer	4.76e-05	0.000159	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IGF1—urinary bladder cancer	4.73e-05	0.000158	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—HRAS—urinary bladder cancer	4.73e-05	0.000158	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MMP9—urinary bladder cancer	4.73e-05	0.000158	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CDKN1A—urinary bladder cancer	4.71e-05	0.000158	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PTEN—urinary bladder cancer	4.7e-05	0.000157	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL2—urinary bladder cancer	4.68e-05	0.000156	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—EP300—urinary bladder cancer	4.66e-05	0.000156	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MMP9—urinary bladder cancer	4.65e-05	0.000156	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CDKN1A—urinary bladder cancer	4.64e-05	0.000155	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PTEN—urinary bladder cancer	4.63e-05	0.000155	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—EP300—urinary bladder cancer	4.62e-05	0.000155	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.62e-05	0.000155	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CXCL8—urinary bladder cancer	4.58e-05	0.000153	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCND1—urinary bladder cancer	4.56e-05	0.000153	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—HRAS—urinary bladder cancer	4.56e-05	0.000152	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL2—urinary bladder cancer	4.55e-05	0.000152	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—SRC—urinary bladder cancer	4.53e-05	0.000152	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CXCL8—urinary bladder cancer	4.53e-05	0.000152	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—HRAS—urinary bladder cancer	4.5e-05	0.000151	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—SRC—urinary bladder cancer	4.5e-05	0.00015	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—EP300—urinary bladder cancer	4.48e-05	0.00015	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CREBBP—urinary bladder cancer	4.46e-05	0.000149	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCND1—urinary bladder cancer	4.44e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MMP9—urinary bladder cancer	4.43e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MYC—urinary bladder cancer	4.42e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CDKN1A—urinary bladder cancer	4.41e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—EP300—urinary bladder cancer	4.41e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PTEN—urinary bladder cancer	4.4e-05	0.000147	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IGF1—urinary bladder cancer	4.4e-05	0.000147	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL2—urinary bladder cancer	4.38e-05	0.000147	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—EGFR—urinary bladder cancer	4.38e-05	0.000146	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—MYC—urinary bladder cancer	4.38e-05	0.000146	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SRC—urinary bladder cancer	4.36e-05	0.000146	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NAT2—urinary bladder cancer	4.35e-05	0.000146	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—RHOA—urinary bladder cancer	4.34e-05	0.000145	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL2—urinary bladder cancer	4.33e-05	0.000145	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—EGFR—urinary bladder cancer	4.32e-05	0.000144	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MMP9—urinary bladder cancer	4.31e-05	0.000144	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CDKN1A—urinary bladder cancer	4.29e-05	0.000144	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SRC—urinary bladder cancer	4.29e-05	0.000143	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PTEN—urinary bladder cancer	4.28e-05	0.000143	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCND1—urinary bladder cancer	4.27e-05	0.000143	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCND1—urinary bladder cancer	4.22e-05	0.000141	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—EP300—urinary bladder cancer	4.2e-05	0.00014	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MMP9—urinary bladder cancer	4.15e-05	0.000139	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—KRAS—urinary bladder cancer	4.14e-05	0.000138	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CDKN1A—urinary bladder cancer	4.13e-05	0.000138	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PTEN—urinary bladder cancer	4.12e-05	0.000138	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MMP9—urinary bladder cancer	4.1e-05	0.000137	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—EP300—urinary bladder cancer	4.08e-05	0.000137	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CDKN1A—urinary bladder cancer	4.08e-05	0.000137	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SRC—urinary bladder cancer	4.08e-05	0.000137	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KRAS—urinary bladder cancer	4.08e-05	0.000136	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PTEN—urinary bladder cancer	4.07e-05	0.000136	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—MYC—urinary bladder cancer	4.06e-05	0.000136	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—RHOA—urinary bladder cancer	4.03e-05	0.000135	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MYC—urinary bladder cancer	4.03e-05	0.000135	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ERBB2—urinary bladder cancer	4.02e-05	0.000134	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—EGFR—urinary bladder cancer	3.97e-05	0.000133	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SRC—urinary bladder cancer	3.97e-05	0.000133	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—EGFR—urinary bladder cancer	3.94e-05	0.000132	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—EP300—urinary bladder cancer	3.93e-05	0.000131	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MYC—urinary bladder cancer	3.91e-05	0.000131	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—EP300—urinary bladder cancer	3.88e-05	0.00013	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MYC—urinary bladder cancer	3.84e-05	0.000129	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SRC—urinary bladder cancer	3.82e-05	0.000128	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—EGFR—urinary bladder cancer	3.82e-05	0.000128	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CXCL8—urinary bladder cancer	3.81e-05	0.000127	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SRC—urinary bladder cancer	3.78e-05	0.000126	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—EGFR—urinary bladder cancer	3.76e-05	0.000126	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.76e-05	0.000126	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—KRAS—urinary bladder cancer	3.75e-05	0.000126	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ERBB2—urinary bladder cancer	3.73e-05	0.000125	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KRAS—urinary bladder cancer	3.72e-05	0.000125	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MYC—urinary bladder cancer	3.66e-05	0.000122	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL2—urinary bladder cancer	3.64e-05	0.000122	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—urinary bladder cancer	3.63e-05	0.000121	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KRAS—urinary bladder cancer	3.61e-05	0.000121	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—EGFR—urinary bladder cancer	3.58e-05	0.00012	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MYC—urinary bladder cancer	3.56e-05	0.000119	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KRAS—urinary bladder cancer	3.55e-05	0.000119	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCND1—urinary bladder cancer	3.55e-05	0.000119	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CXCL8—urinary bladder cancer	3.54e-05	0.000118	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—HRAS—urinary bladder cancer	3.52e-05	0.000118	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—EGFR—urinary bladder cancer	3.48e-05	0.000116	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ENO2—urinary bladder cancer	3.48e-05	0.000116	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	3.48e-05	0.000116	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—HRAS—urinary bladder cancer	3.47e-05	0.000116	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.46e-05	0.000116	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MMP9—urinary bladder cancer	3.44e-05	0.000115	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CDKN1A—urinary bladder cancer	3.43e-05	0.000115	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MYC—urinary bladder cancer	3.43e-05	0.000115	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PTEN—urinary bladder cancer	3.42e-05	0.000114	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MYC—urinary bladder cancer	3.39e-05	0.000113	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL2—urinary bladder cancer	3.38e-05	0.000113	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KRAS—urinary bladder cancer	3.38e-05	0.000113	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.37e-05	0.000113	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—EGFR—urinary bladder cancer	3.35e-05	0.000112	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.32e-05	0.000111	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—EGFR—urinary bladder cancer	3.31e-05	0.000111	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—urinary bladder cancer	3.31e-05	0.000111	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCND1—urinary bladder cancer	3.3e-05	0.00011	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KRAS—urinary bladder cancer	3.29e-05	0.00011	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—EP300—urinary bladder cancer	3.27e-05	0.000109	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—urinary bladder cancer	3.21e-05	0.000107	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MMP9—urinary bladder cancer	3.2e-05	0.000107	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—HRAS—urinary bladder cancer	3.19e-05	0.000107	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	3.19e-05	0.000107	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PTEN—urinary bladder cancer	3.18e-05	0.000106	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SRC—urinary bladder cancer	3.18e-05	0.000106	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KRAS—urinary bladder cancer	3.17e-05	0.000106	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—HRAS—urinary bladder cancer	3.16e-05	0.000106	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—urinary bladder cancer	3.16e-05	0.000106	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KRAS—urinary bladder cancer	3.13e-05	0.000105	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—HRAS—urinary bladder cancer	3.07e-05	0.000103	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—EP300—urinary bladder cancer	3.04e-05	0.000102	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—HRAS—urinary bladder cancer	3.02e-05	0.000101	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—urinary bladder cancer	3e-05	0.0001	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SRC—urinary bladder cancer	2.95e-05	9.87e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—urinary bladder cancer	2.92e-05	9.77e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—HRAS—urinary bladder cancer	2.87e-05	9.61e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MYC—urinary bladder cancer	2.85e-05	9.52e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—urinary bladder cancer	2.81e-05	9.41e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.8e-05	9.38e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—HRAS—urinary bladder cancer	2.8e-05	9.35e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—EGFR—urinary bladder cancer	2.78e-05	9.31e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—urinary bladder cancer	2.78e-05	9.3e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.72e-05	9.1e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—HRAS—urinary bladder cancer	2.69e-05	9e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—HRAS—urinary bladder cancer	2.66e-05	8.89e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MYC—urinary bladder cancer	2.65e-05	8.85e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KRAS—urinary bladder cancer	2.63e-05	8.79e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—EGFR—urinary bladder cancer	2.59e-05	8.65e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KRAS—urinary bladder cancer	2.44e-05	8.17e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.37e-05	7.93e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.34e-05	7.82e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—urinary bladder cancer	2.34e-05	7.81e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.26e-05	7.57e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HRAS—urinary bladder cancer	2.23e-05	7.47e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.17e-05	7.27e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—urinary bladder cancer	2.17e-05	7.26e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.15e-05	7.19e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.15e-05	7.19e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HRAS—urinary bladder cancer	2.08e-05	6.95e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.06e-05	6.88e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.02e-05	6.76e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.9e-05	6.35e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.54e-05	5.15e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.48e-05	4.95e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.21e-05	4.05e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.06e-05	3.53e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.01e-05	3.37e-05	CbGpPWpGaD
